Recently, it was shown that CXCL13-CXCR5 co-expression in breast cancer patients highly correlates with lymph node metastases, suggesting CXCL13-CXCR5 axis as a potentially important therapeutic target in advanced metastatic breast cancer16. Here, CXCL13 is linked to breast carcinoma.